A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VES001 in Healthy Participants
Clinical trial NCT06226064 · COMPLETED
Trial details
- NCT number
- NCT06226064
- Sponsor
- Vesper Biotechnologies ApS
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-11
- Primary completion
- 2024-07-26
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.